BHC - Bausch Health Companies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BHC is currently covered by 7 analysts with an average price target of $9.42. This is a potential upside of $4 (73.8%) from yesterday's end of day stock price of $5.42.

Bausch Health Companies's activity chart (see below) currently has 162 price targets and 122 ratings on display. The stock rating distribution of BHC is 63.16% HOLD, 10.53% SELL and 26.32% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.6% with an average time for these price targets to be met of 172.95 days.

Highest price target for BHC is $10, Lowest price target is $3, average price target is $9.14.

Most recent stock forecast was given by DOUGLAS MIEHM from RBC on 30-Jan-2025. First documented stock forecast 23-Jul-2018.

Currently out of the existing stock ratings of BHC, 12 are a HOLD (63.16%), 2 are a SELL (10.53%), 5 are a BUY (26.32%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$10

$4.56 (83.82%)

$11

3 months 3 days ago
(30-Jan-2025)

12/24 (50%)

$2.54 (34.05%)

252

Buy

$10

$4.56 (83.82%)

$14

7 months 14 days ago
(19-Sep-2024)

0/3 (0%)

$1.82 (22.25%)

Sell

$3

$-2.44 (-44.85%)

$9

9 months 1 days ago
(02-Aug-2024)

11/14 (78.57%)

$-2.63 (-46.71%)

201

Hold

$7

$1.56 (28.68%)

9 months 8 days ago
(25-Jul-2024)

1/1 (100%)

$1.12 (19.05%)

53

Buy

$16

$10.56 (194.12%)

$9.5

1 years 7 months 13 days ago
(20-Sep-2023)

4/5 (80%)

$7.66 (91.85%)

143

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BHC (Bausch Health Companies) average time for price targets to be met?

On average it took 172.95 days on average for the stock forecasts to be realized with a an average price target met ratio 57.6

Which analyst has the current highest performing score on BHC (Bausch Health Companies) with a proven track record?

DAVID MARIS

Which analyst has the most public recommendations on BHC (Bausch Health Companies)?

David Maris has 19 price targets and 21 ratings on BHC

Which analyst is the currently most bullish on BHC (Bausch Health Companies)?

Raghuram Selvaraju with highest potential upside - $49.56

Which analyst is the currently most reserved on BHC (Bausch Health Companies)?

David Amsellem with lowest potential downside - -$2.44

Bausch Health Companies in the News

Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations

Bausch Health Companies (NYSE:BHC) First Quarter 2025 Results Key Financial Results Revenue: US$2.26b (up 4.9% from 1Q 2024). Net loss: US$58.0m (loss narrowed by 9.4% from 1Q 2024). US$0.16 loss per share (improved from US$0.17 loss in 1Q 2024). Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments...

Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down

Shares of Bausch Health Companies Inc. BHC declined 3.81% after the company reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share of 59 cents missed the Zacks Consensus Estimate of 83 cents. The earnings were also down from 60 cents in the year-ago quarter. Total revenues of $2.26 billion were up 5% year over year....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?